secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001213900-25-085213
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed to participate in H.C. Wainwright 27th Annual Global Investment Conference
--------------------------------------------------------------------------------

- Conference takes place September 8-10, 2025 in New York.
- Management will conduct one-on-one investor meetings and a corporate presentation is available online.
- COO Michael Woudenberg will highlight pipeline updates including INM-901 Alzheimer's program data from AAIC 2025.
- No new financial or operational results disclosed; presentation is for investor outreach.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390025085213/0001213900-25-085213-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390025085213/ea0256293-8k_inmed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-085213

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer